Navigation Links
Aethon's Train-Themed Delivery Robot Available To Children's Hospitals Nationwide
Date:7/17/2008

TUG Delivers Cheer, Medication and Equipment to Young Patients and Helps

Raise Money for Make-A-Wish Foundation

PITTSBURGH, July 17 /PRNewswire/ -- Aethon Inc. today announced general availability of its train-themed "JR" autonomous mobile robot to children's hospitals across the country and that Aethon will make a donation to the Make- A-Wish Foundation for each JR TUG that is deployed. The JR TUG is currently delivering equipment to children at Children's Hospital of Wisconsin and medication to children in North Carolina at Carolinas Healthcare Systems in addition to the original implementation at UCSF.

Modeled after the title character in the children's book "The Little Engine that Could," JR was originally developed to help grant a wish for Jericho Rajninger, a seven-year old leukemia patient from Larkspur, California, and was donated to UCSF Children's Hospital through the Make-A- Wish Foundation.

As part of his chemotherapy treatment Jericho had to take more than 4,000 pills. He realized that the prospect of all that medicine could be frightening for other children. Jericho believed that having the medications delivered by a robot modeled after a train might make the prospect of all those pills more pleasant.

"We were honored to make Jericho's wish to help other sick children a reality," said Aldo Zini, CEO of Aethon. "We are extremely pleased that the JR robots are being deployed in other children's hospitals and hope that they will in some sense help sick children and their parents nationwide cope with a difficult experience."

JR is based on Aethon's TUG, a mobile autonomous robot that transports medical equipment and supplies. JR has drawers in its "caboose" from which medications can be drawn by nurses. The robot also features a conductor who speaks to children with the voice of legendary voice over actor Don LaFontaine. "Look out, here I come," "Thanks, from the bottom of my caboose," "Pardon my
'/>"/>

SOURCE Aethon
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
2. Serta Brings Sweet Dreams and a Special Delivery to Deserving Women
3. Dr. Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication, Quality Research in Health Care
4. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
5. Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
6. Developing a modular, nanoparticle drug delivery system
7. QLT acquires leading edge ocular drug delivery system from ForSight Labs
8. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
9. HHS Secretary Leavitt Signs Agreement With Canada to Improve Indigenous Health Care Delivery and Access
10. LeMaitre Vascular Launches Next-Generation Stent Graft Delivery System
11. it Girl Public Relations Adds O.N.I. New Organic Food Delivery Service to Its Lifestyle Division
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Delinquent boys at increased risk of premature death and disability by middle age 2Health News:Delinquent boys at increased risk of premature death and disability by middle age 3Health News:Minneapolis Dentists, Shamblott Family Dentistry, Ease the Pain and Cost of Emergency Dental Procedures 2Health News:Urine Sample May Reveal Sleep Disorder in Kids 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:NBTY To Webcast Presentation; Wedbush Securities California Dreamin' Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009 2Health News:NBTY To Webcast Presentation; Wedbush Securities California Dreamin' Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009 3Health News:NBTY To Webcast Presentation; Wedbush Securities California Dreamin' Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009 4
Other Medicine News:Health News:Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective 2Health News:Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective 3Health News:Artist Neera Dahiya Featured at Silent Auction Held During HealthCorps' Green Garden Gala 2Health News:Artist Neera Dahiya Featured at Silent Auction Held During HealthCorps' Green Garden Gala 3Health News:FertilityTies.com Convention Open to the Public, June 6, 1-5 PM at The Hilton New York Hotel, MDs to Lead Discussion on Timely Fertility Topics 2Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 2Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 3Health News:Encision Reports Fourth Quarter and Fiscal Year 2009 Results 2Health News:Encision Reports Fourth Quarter and Fiscal Year 2009 Results 3Health News:Encision Reports Fourth Quarter and Fiscal Year 2009 Results 4